[1] Siddiqui Z A, Walker A, Pirwani M M, et al. Allergic rhinitis: diagnosis and management[J].Br J Hosp Med (Lond),2022,83(2):1-9.
[2] Kumar I A, Paswan S K, Sinha B K, et al. Effectiveness of bilastine and fexofenadine among allergic rhinitis patients in Ranchi, Jharkhand, India[J].Bioinformation,2022,18(6):596-599.
[3] 谢柳,李淑芳,谭业农,等. 粉尘螨滴剂结合鼻腔负压冲洗对CRS伴AR术后鼻纤毛功能及炎症因子的影响[J].中南医学科学杂志,2023,51(5):686-688.
[4] Bai J, Tan B K, Kato A. Endotypic heterogeneity and pathogenesis in chronic rhinosinusitis[J].Curr Opin Allergy Clin Immunol,2024,24(1):1-8.
[5] 中华耳鼻咽喉头颈外科杂志编辑委员会鼻科组,中华医学会耳鼻咽喉头颈外科学分会鼻科学组. 中国变应性鼻炎诊断和治疗指南(2022年,修订版)[J].中华耳鼻咽喉头颈外科杂志,2022,57(2):106-129.
[6] 中华医学会耳鼻咽喉科学分会.变应性鼻炎诊断标准及疗效评定标准(1997年修订,海口)[J].中华耳鼻咽喉科杂志,1998,33(3):134-135.
[7] Wise S K, Damask C, Roland L T, et al. International consensus statement on allergy and rhinology: allergic rhinitis-2023[J].Int Forum Allergy Rhinol,2023,13(4):293-859.
[8] 苏莹,徐能,黄海平,等. 变应性鼻炎舌下免疫治疗疗效的临床评估[J].医学研究生学报,2022,35(3):291-295.
[9] 范嘉佳,刘海兵,龙苹苹,等. CysLTR1基因多态性与孟鲁司特治疗变应性鼻炎患儿反应性的关系[J].中国耳鼻咽喉颅底外科杂志,2022,28(2):72-77.
[10] Khalfaoui L, Symon F A, Couillard S, et al. Airway remodelling rather than cellular infiltration characterizes both type2 cytokine biomarker-high and -low severe asthma[J].Allergy,2022,77(10):2974-2986.
[11] 刘明宇,王风君. 外周血B细胞活化因子水平对变应性鼻炎患者病情严重程度的预测价值[J].中国耳鼻咽喉颅底外科杂志,2023,29(3):64-68.
[12] 吴凤萍,崔丹丹,王怡恺,等. 血清BAFF预测聚乙二醇干扰素-α治疗非活动性HBsAg携带者临床治愈的效能分析[J].实用肝脏病杂志,2022,25(6):780-783.
[13] Al-khreisat M J, Hussain F A, Abdelfattah A M, et al. The role of NOTCH1, GATA3, and c-MYC in T cell non-hodgkin lymphomas[J].Cancers (Basel),2022,14(11):2799.
[14] Liu X, Wang B F, Wang Y C, et al. Loss of function of GATA3 regulates FRA1 and c-FOS to activate EMT and promote mammary tumorigenesis and metastasis[J].Cell Death Dis,2023,14(6):370.
[15] 孙柳,焦沃尔,孔勇刚,等. GATA3+Treg细胞在变应性鼻炎中的表达及意义[J].南方医科大学学报,2023,43(2):280-286. |
2026, Vol. 43 
